stockrowAquestive Therapeutics, Inc. (AQST) vs Ironwood Pharmaceuticals, Inc. (IRWD)
- Aquestive Therapeutics, Inc. AQST 3.64 −4.21%
- Ironwood Pharmaceuticals, Inc. IRWD 3.94 +4.51%
Aquestive Therapeutics, Inc. and Ironwood Pharmaceuticals, Inc. are both Drug Manufacturers Specialty & Generic companies. Ironwood Pharmaceuticals, Inc. is the larger, with a market value of $665.9M against $460.0M — 1.4× the size. Aquestive Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Ironwood Pharmaceuticals, Inc. trades at 4.3×. Ironwood Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 18.1% against 12.5%. Ironwood Pharmaceuticals, Inc. has the higher net margin (37.4% vs −162.3%) and the higher return on invested capital (0.00% vs 0.00%). Across the 17 metrics below, Ironwood Pharmaceuticals, Inc. leads on 12 and Aquestive Therapeutics, Inc. on 5.
Valuation
Profitability
| Metric | AQST | IRWD | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 65.34% | 100.00% | 53.51% |
| Operating margin | (114.12%) | 62.91% | 0.00% |
| Net margin | (162.33%) | 37.38% | (2.45%) |
| Free cash flow margin | (83.33%) | 51.31% | 0.00% |
| Return on equity | 211.59% | (82.81%) | (0.80%) |
| Return on assets | (56.05%) | 43.58% | (1.67%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack